These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
818 related articles for article (PubMed ID: 25952733)
1. Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis. Goense L; van Rossum PS; Reitsma JB; Lam MG; Meijer GJ; van Vulpen M; Ruurda JP; van Hillegersberg R J Nucl Med; 2015 Jul; 56(7):995-1002. PubMed ID: 25952733 [TBL] [Abstract][Full Text] [Related]
2. Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis. Goense L; Meziani J; van Rossum PSN; Wessels FJ; Meijer GJ; Lam MGEH; van Hillegersberg R; Ruurda JP Nucl Med Commun; 2018 Jul; 39(7):645-651. PubMed ID: 29672463 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis. Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034 [TBL] [Abstract][Full Text] [Related]
4. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis. Kroese TE; Goense L; van Hillegersberg R; de Keizer B; Mook S; Ruurda JP; van Rossum PSN Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29917073 [TBL] [Abstract][Full Text] [Related]
5. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
6. 18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis. Wu LM; Hu JN; Hua J; Gu HY; Zhu J; Xu JR J Gastroenterol Hepatol; 2012 Mar; 27(3):472-80. PubMed ID: 21916986 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis. Xiao Y; Wang L; Jiang X; She W; He L; Hu G Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of surveillance Kim SJ; Hyun SH; Moon SH; Lee KS; Sun JM; Oh D; Ahn YC; Zo JI; Shim YM; Choi JY Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1850-1858. PubMed ID: 31222387 [TBL] [Abstract][Full Text] [Related]
10. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472 [TBL] [Abstract][Full Text] [Related]
11. Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma. Purandare NC; Pramesh CS; Karimundackal G; Jiwnani S; Agrawal A; Shah S; Kulkarni M; Laskar SG; Rangarajan V Nucl Med Commun; 2014 Aug; 35(8):864-9. PubMed ID: 24751701 [TBL] [Abstract][Full Text] [Related]
12. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma. Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies. Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131 [TBL] [Abstract][Full Text] [Related]
14. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis. Wei J; Pei S; Zhu X Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126 [TBL] [Abstract][Full Text] [Related]
15. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study. Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma. Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis. Sheikhbahaei S; Taghipour M; Ahmad R; Fakhry C; Kiess AP; Chung CH; Subramaniam RM AJR Am J Roentgenol; 2015 Sep; 205(3):629-39. PubMed ID: 26295652 [TBL] [Abstract][Full Text] [Related]
18. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis. Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling. Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558 [TBL] [Abstract][Full Text] [Related]
20. Han EJ; O JH; Yoo IR; Kim YS; Kim MS; Kang JH; Choi WH Hell J Nucl Med; 2017; 20(2):134-140. PubMed ID: 28697190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]